Acute coronary syndrome patients had a malignant neoplasia incidence of 17.8 cases per 1000 person-years, which was approximately three times higher than the general population.
Cohort (n=589)
Yes
What is the incidence and prognosis of malignant neoplasia in patients following an acute coronary syndrome?
Patients with acute coronary syndrome have a higher incidence of malignancy than the general population, and developing a neoplasm post-ACS is associated with a worse prognosis than having a preexisting neoplasia.
AIM: To investigate the clinical features and incidence of malignant neoplasia during 17 years of follow-up in an unselected sample of patients with acute coronary syndrome (ACS). METHODS: The Adria, Bassano, Conegliano, and Padova Hospital-4 Study on Heart Disease is an ongoing, prospective study of an unbiased population of patients with ACS. Baseline clinical and laboratory data were obtained during the first 7 days of hospitalization at three different intensive coronary care units. The current study included data from 589 patients with ACS. RESULTS: At enrollment, 19 patients had confirmed neoplasia. During follow-up, 99 additional patients developed malignant neoplastic disease. The incidence rate was 17.8 cases per 1000 person-years, which was about three times higher than that observed in the general population. Patients had a shorter duration of neoplasia when they developed it after enrollment compared with those with preexisting neoplasia hazard ratio = 2.0 (1.5-2.6), P = 0.001. Patients with neoplasia who died during follow-up had an earlier onset of neoplasia hazard ratio = 1.8 (1.1-2.9), P = 0.01 and shorter duration than survivors hazard ratio = 4.1 (2.4-7.0), P < 0.0001. The estimated time to diagnosis of neoplasia indicated elderly patients had a significantly higher risk than younger people during the 17 years of follow-up. After the onset of neoplasia, survival time declined more sharply in the elderly than younger people. CONCLUSION: The long-term prospective study showed that patients with ACS have a higher incidence of malignancy than the general population. Those who develop neoplasm after being diagnosed with ACS have a worse prognosis than patients with a preexisting neoplasia.
Berton et al. (Thu,) conducted a cohort in Acute coronary syndrome (n=589). Acute coronary syndrome vs. General population was evaluated on Incidence of malignant neoplasia. Acute coronary syndrome patients had a malignant neoplasia incidence of 17.8 cases per 1000 person-years, which was approximately three times higher than the general population.